SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-046070
Filing Date
2013-08-14
Accepted
2013-08-14 17:52:46
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v351889_10q.htm 10-Q 314961
2 EXHIBIT 31.1 v351889_ex31-1.htm EX-31.1 8130
3 EXHIBIT 32.1 v351889_ex32-1.htm EX-32.1 4769
  Complete submission text file 0001144204-13-046070.txt   5937378

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20130630.xml EX-101.INS 538919
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20130630.xsd EX-101.SCH 52975
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20130630_cal.xml EX-101.CAL 44426
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20130630_def.xml EX-101.DEF 237659
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20130630_lab.xml EX-101.LAB 305460
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20130630_pre.xml EX-101.PRE 271922
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 131039173
SIC: 2834 Pharmaceutical Preparations